HYMS: the future. What we have Established teaching programme and innovative curriculum Good joint working with the NHS Excellent financial arrangement.

Slides:



Advertisements
Similar presentations
Cancer Research UK strategy and funding Simon Vincent.
Advertisements

NIHR Delivering Better Health Through Training Researchers 19 September 2011 Dr David Cox Deputy Director – Research Faculty.
NIHR Delivering Better Health 20 November 2012, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Page 1 An Academic Health Sciences Centre at the heart of a world city....
Presented by: Jerry Legge Associate Provost for Academic Planning (Interim), and Professor of Public Administration and Policy (SPIA) Provost Advisory.
What is commissioning? Paul McManus Pharmacist Advisor Yorkshire and the Humber Office North of England Specialised Commissioning Group North of England.
West Midlands Academic Health Science Network
West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.
West Midlands Academic Health Science Network
We need user-led research more now than ever before…
Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.
Understanding Diabetes Dr Gill Hood North Thames Clinical Research Network Barts Health NHS Trust
DFID review of impact of research on development – an MRC perspective
Welcome to the NIHR Peter Knight, Deputy Director Research Contracting, Information Intelligence and Stakeholder Engagement NIHR Trainees Meeting Leeds.
Update: Operational Delivery Networks Denise McLellan Transitional Lead, Networks and Senates, Midlands and East November 2012.
CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.
Clinical academic training in a changing landscape. JP Neilson NIHR Dean for Training [DATE] Imperial 2011.
University of Nottingham Facilitating Innovation Through Collaboration.
Mother and Infant Research Unit MIRU Department of Health Sciences University of York November 2005.
Academic Surgery – Future Tense? Norman S Williams Centre for Academic Surgery - Barts and The London School of Medicine & Dentistry.
Medicine, Nursing and Health Sciences School of Public Health & Preventive Medicine (SPHPM) Biomedical Science (BMS) Units,
Improving Clinical Research across the UK – Who, Why, How? Matthew Hallsworth, Communications Programme Manager Marianne Miles, Patient and Public Involvement.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
1 What is Hospice Palliative Care? The Canadian Hospice Palliative Care Association defines hospice palliative care as a special kind of health care for.
NISCHR Research Infrastructure for Wales Angela Martin Learning Disabilities, Autism and Neurodevelopmental disorders network (LDAN) Conference April 2013.
The Benefits of a Research Active Trust. What is Research? Research is about finding out something new and innovative by combining theory with evidence.
SPORT AND ACTIVE LEISURE BUCS CONFERENCE National Skills Academy & SkillsActive.
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
The “Something More”. Demands: A cost beyond spoon feeding More than good intentions More than the ambitions or any other notions of man That gateways.
AHSN Stakeholder Event Centre for Life, Newcastle Tuesday 23 rd June 2015 Patient Safety Collaboratives: the North East approach Tony Roberts, Interim.
School of Healthcare FACULTY OF MEDICINE AND HEALTH The design and delivery of an interdisciplinary MSc in Advanced Practice Professor Claire Hale.
Progress in the RNOH-IOMS Joint Academic Strategy David Marsh Professor of Clinical Orthopaedics, Institute of Orthopaedics and Musculoskeletal Science.
Research Retreat Welcome and Introduction Irene Leigh Head of College.
Welcome to SURF 09 Involving Patients and the Public in HCAI Research.
Health Innovation and Education Clusters Review purpose of HIECs Outline Cumbria and Lancs Outline Greater Manchester.
The New Public Health System
Wessex LETB The Changing Landscape Paul Holmes, Managing Director.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
RESEARCH AND INNOVATION Mr Ken Lavery, Medical Director.
Health, Wellbeing and Social Care Scrutiny Committee.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Faculty of Medical Sciences Convocation Saturday 15 th June 2013 Professor Chris Day, PVC FMS.
Presentation/Phenotype
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Creating Britain’s largest General Practice partnership Dr Vish Ratnasuriya Managing Partner and Chair of Transitional Board.
Strategic Overview Professor Namita Kumar Postgraduate Dean.
Horizon 2020 Overview Jerome de Barros NCP Health.
AACN – Manatt Study In February 2015, the AACN Board of Directors commissioned Manatt Health to conduct a study on how to position academic nursing to.
WE WANT CHANGE! KEEP YOUR GANG. Anna Kime - Integrated Practice Project Manager Who We Are Russell Gurbutt - Senior Lecturer.
Our application to become an NHS Foundation Trust.
Realising MRC’s Vision in Health and Bioinformatics MRC Open Council Meeting July 2014 Janet Valentine Head of Population Health and Informatics.
R&D Report to SL&M Board 17 September 2002 Graham Thornicroft Director of Research & Development Gill Dale Research & Development Manager.
Surrey VCFS Forum Clinical Commissioning Reigate Baptist Church 10 th July 2013 Carol Rowley Patient and Public Engagement Lead East Surrey Clinical Commissioning.
David Taylor The Art of City Making Birmingham 30 October 2004 Developing Medical and Healthcare Potential.
Local Education and Training Boards Tim Gilpin Director of Workforce and Education NHS North of England.
Building the NIHR NIHR: 10 years of delivering health and care research for the nation QEII Centre, London Wednesday 18 May 2016 Professor Dame Sally C.
Strategic Vision Mission: Advancing mental health care through excellence in research and education Professor Martin Orrell Director, Institute of Mental.
Research and Development Dr Julie Hankin Medical Director.
Diabetes Research Network Professor Azeem Majeed Imperial College, London.
R&D Annual Report SLaM Board, Nov 2005
LH Business change team
Money, Medical Education and Beyond
Malcolm Lowe-Lauri Executive Director at CUHP
Health Education England Workforce Strategy - Key Points
Professor Chris Whitty CB FMedSci Chief Scientific Adviser
Opportunities to Pursue a Clinical and Translational Career at Penn Emma A. Meagher, MD Vice Dean for Clinical Research & Chief Clinical Research Officer.
Research for all Sharing good practice in research management
UCD School of Medicine & Medical Science
John Adler Chief Executive, Leicester’s Hospitals
Health Education England Workforce Strategy - Key Points
Presentation transcript:

HYMS: the future

What we have Established teaching programme and innovative curriculum Good joint working with the NHS Excellent financial arrangement with NHS for SIFT A strong national ‘brand’ for medical education moving onto the international stage A sound management system for undergraduate teaching focussed on operational rather than strategic issues.

Medical education and research are not independent but rather inter-dependent ‘Properly planned and carefully conducted medical education is the essential foundation of a comprehensive health service’ ‘In the teaching hospitals care of patients and furtherance of teaching and research should receive equal emphasis’ ‘The further you look back the further you can look forward’ (Churchill 1944) Goodenough Report (1944) Resonates with current priorities –‘Tomorrows Doctors’ & BIGT report 2003 improved national health and increased national wealth Partnership is essential HYMS already highly rated for medical education, so the focus is now on the research component

What we don’t have Well developed HYMS research base Facility for experimental medicine to exploit links with Biology and imaging Joint research with NHS Postgraduate degrees - research and taught Research brand for HYMS Sufficient intercalated degrees Management structure for strategic research development –Record of grants or publication Research income –nil despite around 15 research active academics Physical focus for research

Priorities Create a high quality medical research reputation, environment and culture for HYMS –Exploit existing strengths –Appointments in key areas –Identify research opportunities –Provide research infrastructure Facilities and physical focus Management –Research degrees and taught PG courses –Intercalated degrees Further investment in medical education to maintain an innovative curriculum Increased income to support continuing investment in research and education

What does research in a traditional Medical School look like? 1 Cardiovascular medicine 2 Cancer studies 3 Infection and Immunity 4 Other hospital based subjects 6 Epidemiology / public health 7. Health services research 8. Primary care 9. Psychiatry /clin psychology 14. Biological sciences 15. Preclinical & human biological science

Creating a presence in medical research York recognised as internationally leading in –Health Sciences –Epidemiology, public health, health policy, health economics, health services research, clinical trials –Biology –Infection & Immunity, Cancer, reproduction –Psychology HYMS has invested posts in several of these areas, but not seen as part of the medical school HYMS presents the opportunity to enhance medical research by joint working Need to ’badge’ existing medical research under HYMS

Research Areas for Development; National priorities -MRC Ensure advances at the molecular level are extended quickly to increase our understanding of how cells, organs and organisms behave in health and disease. Major emphasis on translating this laboratory-based work into new and improved treatments, interventions and healthcare service Current priority areas include: –Clinical and public health research –Infections and vaccine research –Global health –Biomarkers Resonate well with research in York But need for translation - the role of HYMS

Translational Research…….. From molecule to man, from patient to population Upon this gifted age, in its dark hour, Rains from the sky a meteoric shower Of facts...they lie unquestioned, uncombined. Wisdom enough to leech us of our ill Is daily spun; but there exists no loom To weave it into fabric. Edna St Vincent Millay from ‘Upon this age that never speaks its mind’

HYMS: Experimental Medicine Unit Experimental medicine is investigation in humans to identify mechanisms of disease, to test the validity and importance of new discoveries or treatments Translates biological findings into man –proof of concept Followed by clinical trials, to translate into clinical practice York is key for experimental medicine –Facility needed to study small numbers of patients in depth –proximate to biology and imaging facilities

HYMS: clinical trials Population base with high morbidity –Not exploited in trials Clinical Research facility in Hull costing £6.5M using HYMS NHS R & D and charitable funding Change in NHS R & D funding and management –Directed research and clinical trials Development of HYMS Comprehensive Local Research Network proposal for the region

R&D Strategy Changes and NHS Trusts: The opportunity All R&D Funding being withdrawn and reallocated to follow activity Strategic aims of redistribution include: –Concentrate funding in key centres of international standing –5 generic Biomedical Research Centres - Cambridge, Guys, Hammersmith, Oxford, UCL –Improve equity of population access to clinical research by element of per capita funding NIHR – Faculty, Projects & Programmes, Facilities The Comprehensive Research Network –National requirements for Comprehensive Local Research Networks Core funding ~ £ K pa per CLRN –Pays for management of the Network, not of research Per capita funding –£1.25m in this area, for 1.64m population Increased activity should equal increased income

NHS R & D Transitional Funding allocations in England by population /7 (£ per capita) England10.39 Greater London46.50 England excluding Greater London 4.22 Yorkshire and Humber4.56 NE Yorks & N Lincs0.87

UK Medical Research Funding % by region or city S/E England London Scotland Edinburgh N/W England Manchester Yorkshire and Humber Leeds W Midlands Birmingham

Recruitment: Key to Realising the Opportunity ‘ Willing is not enough; we must do’ Goethe To link with Biology (IIU) at York –Chair of Experimental Medicine, –Senior Lecturers in Clinical subjects related to immunology eg renal medicine, immunohaematology, –GUM chair and SL To link with Health Science at York Chair and SL in epidemiology and public health To link with Psychology & YNIC Chair and support posts in neuroscience Work with NHS Trusts to align service and HYMS agenda for recruitment where possible Parallel developments in Hull

HYMS: The future Continued innovative education Research reputation –Presentation & Organisation –Facilities - HEMU –Recruitment Success in Education and Research brings further investment and a virtuous cycle of development benefiting HYMS, the Universities, the NHS and the population.

Network Board Accountable to UKCRN Accountable to partner organisations East Yorkshire Research Management Research Nursing Administration North Yorkshire Research Management Research Nursing Administration North Lincs Research Management Research Nursing Administration CLRN Executive Committee Core Management Team Research Facilitators Monitoring Officers Network Trust R&D Committee Locality Teams Proposed HYMS CLRN Structure